Evidence map›Paper›PMID 24766459›Full record

ArticleImmunology2014

Insufficient interleukin-12 signalling favours differentiation of human CD4(+) and CD8(+) T cells into GATA-3(+) and GATA-3(+) T-bet(+) subsets in humanized mice.

Eva Billerbeck, Rachael N Labitt, Kevin Vega, Natalia Frias-Staheli, Marcus Dorner, Jing W Xiao, Charles M Rice, Alexander Ploss

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Targeting cytokine and chemokine signaling pathways for cancer therapy.Signal transduction and targeted therapy · 2024
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Application of Humanized Mice in Immunological Research.Methods in molecular biology (Clifton, N.J.) · 2016
    Review
  14. Article
  15. Article
  16. Review
  17. Translating Treg Therapy in Humanized Mice.Frontiers in immunology · 2015
    Review
  18. In-situ tumor vaccination: Bringing the fight to the tumor.Human vaccines & immunotherapeutics · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Eva BillerbeckLaboratory of Virology and Infectious Disease, Center for the Study of Hepatitis C, The Rockefeller University, New York, NY, USA.
Rachael N Labitt
Kevin Vega
Natalia Frias-Staheli
Marcus Dorner
Jing W Xiao
Charles M Rice
Alexander Ploss
Rockefeller University · US

Funding

VACCINE INDUCED IMMUNITY IN THE YOUNG AND AGEDU19AI057266 · NIAID · EMORY UNIVERSITY · PI Rafi Ahmed · 2003 to 2026
$81.7M
TRANSFORMING TRANSLATIONAL SCIENCE AND EDUCATION TO BENEFIT HUMAN HEALTHUL1RR024143 · NCRR · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY · 2006 to 2011
$49.1M
Modeling human hepatotropic infections in complex tissue organoidsR01DK085713 · NIDDK · ROCKEFELLER UNIVERSITY · PI BHATIA, SANGEETA N., RICE, CHARLES M · 2009 to 2013
$5.6M
NCRR NIH HHS UL1 RR024143NCRR NIH HHS UL1RR024143NIAID NIH HHS U19 AI057266NIAID NIH HHS U19AI057266NIDDK NIH HHS R01 DK085713NIDDK NIH HHS R01DK085713
6 · The paper itself

Abstract

Differentiation of CD4(+) T cells into type 1 or type 2 subsets is mediated by the expression of the opposing lineage defining transcription factors T-bet and GATA-3. However, the existence of GATA-3(+) T-bet(+) CD4(+) T cells in mice suggests functional plasticity of these subsets. Little is known about type 1 and type 2 plasticity of human T-cell subsets in vivo. Here, we show that in the xenogeneic environment of humanized mice, which lacks a functional immune-regulatory network, human CD4(+) and, notably, CD8(+) T cells preferentially differentiate into interleukin (IL)-4(+) GATA-3(+) and IL-4(+) interferon-γ(+) GATA-3(+) T-bet(+) subsets. Treatment with recombinant human IL-12 or expansion of IL-12-producing human dendritic cells in vivo reverted this phenotype and led to the down-regulation of GATA-3 expression. These changes also correlated with improved antiviral immune responses in humanized mice. In conclusion, our study shows the capacity of human CD4(+) and CD8(+) T cells for stable co-expression of GATA-3 and T-bet in humanized mice and reveals a critical role for IL-12 in regulating this phenotype.

Indexed as

Cell DifferentiationHematopoietic Stem Cell TransplantationSignal TransductionAdenoviridaeAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell LineageCells, CulturedDendritic CellsGATA3 Transcription FactorHost-Pathogen InteractionsHumansInjections, IntraperitonealInterferon-gammaInterleukin-12GATA3 protein, humanGATA3 Transcription FactorIFNG protein, humanIL4 protein, humanInterferon-gammaInterleukin-12Interleukin-4T-bet Transcription FactorT-Box Domain Proteinshumanized miceinterleukin-12T-cell plasticity

Identifiers

PMID24766459
PMCPMC4172137
OpenAlexW2056537073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.